Idev Technologies Enrolls First Patient in Stent Clinical Trial

Idev Technologies, Incorporated, an emerging leader in the development and marketing of minimally invasive medical technologies, announced that the first patient was enrolled in the Company’s FDA-approved multi-center clinical trial of its self-expanding Supera stent, a novel stent platform designed for the treatment of biliary and peripheral artery disease in the superficial femoral artery.
Earth Times